TY - JOUR
T1 - Bias due to interval censored outcomes in a study of flare risk after hydroxychloroquine taper/cessation in systemic lupus erythematosus
AU - Kaddoura, Rima
AU - Bernatsky, Sasha
AU - Beauchamp, Marie Eve
AU - Guerra, Steve Ferreira
AU - Almeida-Brasil, Celline C.
AU - Hanly, John G.
AU - Urowitz, Murray
AU - Clarke, Ann E.
AU - Ruiz-Irastorza, Guillermo
AU - Gordon, Caroline
AU - Ramsey-Goldman, Rosalind
AU - Petri, Michelle A.
AU - Ginzler, Ellen M.
AU - Wallace, Daniel J.
AU - Bae, Sang Cheol
AU - Romero-Diaz, Juanita
AU - Dooley, Mary Anne
AU - Peschken, Christine
AU - Isenberg, David
AU - Manzi, Susan
AU - Jacobsen, Søren
AU - Lim, S. Sam
AU - Nived, Ola
AU - Jönsen, Andreas
AU - Kamen, Diane L.
AU - Aranow, Cynthia
AU - Sánchez-Guerrero, Jorge
AU - Gladman, Dafna D.
AU - Fortin, Paul R.
AU - Alarcón, Graciela S.
AU - Merrill, Joan T.
AU - Kalunian, Kenneth
AU - Ramos-Casals, Manuel
AU - Zoma, Asad A.
AU - Askanase, Anca D.
AU - Khamashta, Munther
AU - Bruce, Ian N.
AU - Inanc, Murat
AU - Lukusa, Luck
AU - Abrahamowicz, Michal
N1 - Publisher Copyright:
© 2026 Elsevier Inc.
PY - 2026/7
Y1 - 2026/7
N2 - Objective This study attempted to quantify the bias expected due to partly interval-censored (IC) outcomes in the estimated association between hydroxychloroquine (HCQ) taper/cessation and time to disease flare among individuals with systemic lupus erythematosus (SLE). Methods Using data-driven simulations, we estimated bias expected due to IC using real-world data from the Systemic Lupus International Collaborating Clinics inception cohort. The time-varying exposure of interest was a binary indicator of HCQ tapering/cessation. The composite outcome was lupus flare, defined as lupus hospitalizations or increases in disease activity or medication dose. The two latter components were IC, as they were recorded only at annual assessment, without a precise date. For the unknown IC event times, a “true” event time was randomly generated from a uniform distribution of the time between two assessments. Each simulated sample was analyzed separately imputing unknown event times (for IC outcomes) either at the midpoint or endpoint of the interval between the two adjacent yearly assessments. Results of multivariable Cox proportional hazards models, adjusted for demographics, drugs, and clinical variables, using either “true” or imputed IC event times were compared. Results The 1543 SLE patients were followed for a median of 42.2 months. During follow-up, 396 participants tapered/stopped HCQ and 1187 experienced a flare. The adjusted uncorrected hazard ratio was 1.51 (95% confidence interval: 1.30, 1.75) and 1.40 (95% confidence interval: 1.21, 1.62) for midpoint and endpoint imputations, respectively. Data-driven simulations showed that imputation of IC event times resulted in a small but systematic bias toward the null that was consistently larger for endpoint than for midpoint imputation. Conclusions IC events induced bias toward the null in the estimated association between HCQ taper/cessation and lupus flares. Data-driven simulations are useful for quantitative bias analyses in complex situations, as they allow accounting for relevant characteristics of a particular real-world dataset.
AB - Objective This study attempted to quantify the bias expected due to partly interval-censored (IC) outcomes in the estimated association between hydroxychloroquine (HCQ) taper/cessation and time to disease flare among individuals with systemic lupus erythematosus (SLE). Methods Using data-driven simulations, we estimated bias expected due to IC using real-world data from the Systemic Lupus International Collaborating Clinics inception cohort. The time-varying exposure of interest was a binary indicator of HCQ tapering/cessation. The composite outcome was lupus flare, defined as lupus hospitalizations or increases in disease activity or medication dose. The two latter components were IC, as they were recorded only at annual assessment, without a precise date. For the unknown IC event times, a “true” event time was randomly generated from a uniform distribution of the time between two assessments. Each simulated sample was analyzed separately imputing unknown event times (for IC outcomes) either at the midpoint or endpoint of the interval between the two adjacent yearly assessments. Results of multivariable Cox proportional hazards models, adjusted for demographics, drugs, and clinical variables, using either “true” or imputed IC event times were compared. Results The 1543 SLE patients were followed for a median of 42.2 months. During follow-up, 396 participants tapered/stopped HCQ and 1187 experienced a flare. The adjusted uncorrected hazard ratio was 1.51 (95% confidence interval: 1.30, 1.75) and 1.40 (95% confidence interval: 1.21, 1.62) for midpoint and endpoint imputations, respectively. Data-driven simulations showed that imputation of IC event times resulted in a small but systematic bias toward the null that was consistently larger for endpoint than for midpoint imputation. Conclusions IC events induced bias toward the null in the estimated association between HCQ taper/cessation and lupus flares. Data-driven simulations are useful for quantitative bias analyses in complex situations, as they allow accounting for relevant characteristics of a particular real-world dataset.
KW - Data-driven simulations
KW - Hydroxychloroquine
KW - Interval censoring
KW - Pharmacoepidemiologic methods
KW - Quantitative bias analysis
KW - Systemic lupus erythematosus
UR - https://www.scopus.com/pages/publications/105036681009
UR - https://www.scopus.com/pages/publications/105036681009#tab=citedBy
U2 - 10.1016/j.jclinepi.2026.112261
DO - 10.1016/j.jclinepi.2026.112261
M3 - Article
C2 - 41921830
AN - SCOPUS:105036681009
SN - 0895-4356
VL - 195
JO - Journal of Clinical Epidemiology
JF - Journal of Clinical Epidemiology
M1 - 112261
ER -